Displaying 109 - 116 of 116
Immune-Mediated and Cholestatic Diseases
6

Mirum Pharmaceuticals, Inc: "Not just an itch: The burden of PBC and PSC" - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
6

Mirum Pharmaceuticals, Inc: "Not just an itch: The burden of PBC and PSC" - EASL Congress 2023

View
Liver Tumours
6

Bayer: Advancements in MRI for imaging assessment of HCC:  Practical considerations for differential diagnosis of focal liver lesions - EASL Liver Cancer Summit 2023

View
Liver Tumours
6

Bayer: Advancements in MRI for imaging assessment of HCC:  Practical considerations for differential diagnosis of focal liver lesions - EASL Liver Cancer Summit 2023

View
Liver Tumours
6

Bayer: Advancements in MRI for imaging assessment of HCC:  Practical considerations for differential diagnosis of focal liver lesions - EASL Liver Cancer Summit 2023

View
Liver Tumours
6

Bayer: Advancements in MRI for imaging assessment of HCC:  Practical considerations for differential diagnosis of focal liver lesions - EASL Liver Cancer Summit 2023

View
Liver Tumours
6

Bayer: Advancements in MRI for imaging assessment of HCC:  Practical considerations for differential diagnosis of focal liver lesions - EASL Liver Cancer Summit 2023

View
Liver Tumours
6

Bayer: Advancements in MRI for imaging assessment of HCC:  Practical considerations for differential diagnosis of focal liver lesions - EASL Liver Cancer Summit 2023

View